Market Access & Value Strategy

Securing market access goes far beyond proving clinical benefit. At Catalyse Research, we help organisations navigate the commercial, regulatory, and payer landscapes that ultimately determine whether a therapy reaches patients.

We analyse the factors that influence pricing, reimbursement, and adoption, translating complex evidence into clear, defensible value narratives.

Our approach focuses on aligning clinical outcomes with economic expectations. This enables you to position therapies effectively, shorten time to access, and expand reach across diverse healthcare systems.

By combining market insight with strategic clarity, we support sustainable uptake and long-term commercial success.

Research Design & Analytical Framework

We apply a structured mix of qualitative and quantitative techniques to uncover how value is assessed in real-world settings. This includes payer engagement through advisory boards, alongside advanced pricing and preference modelling to evaluate trade-offs and willingness to pay.

Our work is underpinned by robust economic evaluation, including cost-effectiveness modelling and budget impact assessments. We also develop clear, evidence-backed value propositions tailored for payer discussions.

By integrating these elements with predictive analytics, we deliver practical insights that inform confident, evidence-led market access decisions.